Herbert Raymond Henney
Keine laufenden Positionen mehr
Karriereverlauf von Herbert Raymond Henney
Ehemalige bekannte Positionen von Herbert Raymond Henney
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACORDA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2005 | 01.04.2014 |
SAVIENT PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | - | - |
W WORL | Technik-/Wissenschafts-/F&E-Leiter | - | - |
General Counsel | - | - |
Ausbildung von Herbert Raymond Henney
Temple University (Pennsylvania) | Undergraduate Degree |
Medical University of South Carolina | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
General Counsel | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ACORDA THERAPEUTICS, INC. | Health Technology |
W WORL | Health Technology |
Private Unternehmen | 1 |
---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
- Börse
- Insiders
- Herbert Raymond Henney
- Erfahrung